James R Sulat's Net Worth

$760 Thousand

Estimate Recalculated Nov 1, 2024 06:00AM EST

Who is James R Sulat?

James R Sulat does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include , Arch Therapeutics, Inc., AMAG PHARMACEUTICALS INC., Mallinckrodt plc, EXICURE, INC., MOMENTA PHARMACEUTICALS INC, DONNELLEY R R & SONS CO, MAXYGEN INC, Diadexus, Inc., MOORE WALLACE INC, MEMORY PHARMACEUTICALS CORP, and VANS INC.

SEC CIK

James R Sulat's CIK is 0001229448

Past Insider Trading and Trends

2018 was James R Sulat's most active year for acquiring shares with 9 total transactions. James R Sulat's most active month to acquire stocks was the month of May. 2004 was James R Sulat's most active year for disposing of shares, totalling 11 transactions. James R Sulat's most active month to dispose stocks was the month of May. 2007 saw James R Sulat paying a total of $575,000.00 for 405,000 shares, this is the most they've acquired in one year. In 2011 James R Sulat cashed out on 13,000 shares for a total of $173,020.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+793.57%
5.29M
—
—
5.96M
Apr 27
Form 3
—
0
—
—
0
No matching records found

Arch Therapeutics, Inc. (ARTH) Snapshot price: $4.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 27
Form 4
+49.29%
454.55K
$0.18
$81,818.28
1.38M
Jun 22
Form 4
—
0
—
—
0
Dec 20
Form 4
+42.31%
110K
—
—
370K
Jul 19
Form 4
+13.04%
30K
$0.37
$11,100.00
260K
Jul 16
Form 4
+666.67%
200K
—
—
230K
Feb 3
Form 4
+14.66%
111.11K
—
—
868.93K
May 26
Form 4
∞
30K
—
—
30K
May 3
Form 4
—
0
—
—
0
Aug 19
Form 3
—
0
—
—
0
No matching records found

AMAG PHARMACEUTICALS INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-35.09K
—
—
0
Nov 16
Form 4
+41.37%
10.27K
—
—
35.09K
Jun 2
Form 4
+48.58%
8.12K
—
—
24.82K
May 16
Form 4
+27.26%
3.58K
—
—
16.7K
Jun 7
Form 4
+52.96%
4.54K
—
—
13.13K
May 18
Form 4
+125.01%
4.77K
—
—
8.58K
May 19
Form 4
+53.05%
1.32K
—
—
3.81K
May 21
Form 4
+1,197.92%
2.3K
—
—
2.49K
May 22
Form 4
∞
192
—
—
192
Apr 14
Form 3
—
0
—
—
0
No matching records found

Mallinckrodt plc (MNKTQ) Snapshot price: $0.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-53.12K
—
—
0
Nov 14
Form 4
-35.65%
-29.43K
$1.28
—
53.12K
Jun 16
Form 4
+57.09%
30K
$8.48
$254,475.00
82.55K
Mar 14 - Mar 15
Form 4
+100.00%
26.28K
—
—
52.55K
Jan 3
Form 4
—
0
—
—
0
Aug 16
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found

EXICURE, INC. (XCUR) Snapshot price: $1.74

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jan 2
Form 3
—
0
—
—
0
No matching records found